DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Five Prime Therapeutics, Inc. (FPRX)
« Back to company indexFPRX Chatter Timeline
Stock Ticker for FPRX
Most Active Tweeters for FPRX
| User | Tweets |
|---|---|
| @BlogYomi | 8 |
| @thefinreviewer | 4 |
| @bibeypost_stock | 3 |
| @mmahotstuff1 | 3 |
| @whatsonthorold2 | 3 |
Recent Tweets for FPRX
 |
@BlogYomi Celsion Corporation $FPRX Contrasting side by side https://t.co/irMVmQnFcV March 21st 2019, 10:03pm |
 |
@registrarjourn Five Prime Therapeutics $FPRX Raised to “Hold” at ValuEngine https://t.co/nYysGmh1j7 March 21st 2019, 12:03pm |
 |
@EnterpriseLeade Five Prime Therapeutics $FPRX Raised to “Hold” at ValuEngine https://t.co/gZY3C9Thq8 March 21st 2019, 12:03pm |
 |
@thefinreviewer ChemoCentryx Inc. $FPRX Contrasting side by side https://t.co/hIKM3QXKrK March 21st 2019, 12:03am |
 |
@dailypoliticaln Five Prime Therapeutics $FPRX Stock Rating Upgraded by ValuEngine https://t.co/GOwuw0CnHe March 20th 2019, 10:03pm |
 |
@ZolmaxNews Five Prime Therapeutics $FPRX Stock Rating Upgraded by ValuEngine https://t.co/0pf2qqOOKf March 20th 2019, 10:03pm |
|
@BlogYomi Comparing of ARCA biopharma Inc. $FPRX https://t.co/lJULWFQmOs March 19th 2019, 9:03pm |
 |
@StockTexts $FPRX Five Prime Therapeutics, Inc. SEC Filing: Form CT ORDER https://t.co/yydKONJWGn March 19th 2019, 11:03am |
 |
@ProVesting $FPRX: Will Five Prime Therapeutics Continue to Surge Higher?: https://t.co/MkTlp0TIVV March 19th 2019, 8:03am |
 |
@mmahotstuff1 Does This Provide a Reason to Buy Five Prime Therapeutics, Inc. $FPRX? The Stock Has Formed Inverse H&S Chart Patte… https://t.co/yNyiR5mj7H March 19th 2019, 7:03am |
 |
@bibeypost_stock Five Prime Therapeutics, Inc. $FPRX on Focus After Forming Bullish Inverse Head & Shoulders Chart Pattern https://t.co/mZ8BGkToAQ March 19th 2019, 7:03am |
|
@BlogYomi As Five Prime Therapeutics $FPRX Market Valuation Declined, Bvf Decreased by $5.40 Million Its Stake; Nordea Invest… https://t.co/RUWqXJlU11 March 18th 2019, 4:03pm |
 |
@whatsonthorold2 Five Prime Therapeutics Inc $FPRX Institutional Investors Sentiment Index Up in Q4 2018 https://t.co/vUz9eqL6Ra March 17th 2019, 1:03pm |
|
@BlogYomi Reviewing ArQule Inc. $FPRX's results https://t.co/iHN30YwNMy March 17th 2019, 2:03am |
|
@dailypoliticaln Analysts Set Five Prime Therapeutics Inc $FPRX Target Price at $24.29 https://t.co/BTQiVujLl2 March 16th 2019, 11:03pm |
 |
@TickerReport Five Prime Therapeutics Inc $FPRX Given Average Rating of “Buy” by Analysts https://t.co/jAEAmx5auy March 16th 2019, 11:03pm |
|
@BlogYomi Athersys Inc. $FPRX https://t.co/W84BS8FwoG March 16th 2019, 9:03pm |
|
@thefinreviewer Reviewing Aclaris Therapeutics Inc. $FPRX's results https://t.co/9lGPY8tjz1 March 16th 2019, 6:03pm |
 |
@1MinuteStock Wondering about #sentiment indicator for $FPRX? The Short Ratio is 6.75% https://t.co/0mPOVO3pb3 March 16th 2019, 4:03pm |
|
@1MinuteStock Recommendation #HOLD for $FPRX with UB rating - 2.77 out of 5. https://t.co/swI02gtQKq March 16th 2019, 8:03am |
|
@thefinreviewer Reviewing Navidea Biopharmaceuticals Inc $FPRX's results https://t.co/HBcVCtGYuv March 16th 2019, 12:03am |
|
@BlogYomi Five Prime Therapeutics $FPRX Market Valuation Declined While Rock Springs Capital Management LP Decreased Its Hold… https://t.co/WFJXsxKmUA March 15th 2019, 1:03pm |
 |
@WeekHerald Five Prime Therapeutics Inc $FPRX Expected to Post Quarterly Sales of $4.81 Million https://t.co/1jzkutMIzj March 14th 2019, 9:03pm |
 |
@ThisLincolnian Five Prime Therapeutics Inc $FPRX Expected to Announce Quarterly Sales of $4.81 Million https://t.co/tyMikxvMpr March 14th 2019, 9:03pm |
|
@bibeypost_stock Could Five Prime Therapeutics, Inc. $FPRX Gain Strenght After Forming Bullish Inverse Head & Shoulders Chart Patter… https://t.co/MniB7n1bei March 14th 2019, 10:03am |
 |
@reurope_stock Five Prime Therapeutics, Inc. $FPRX on Focus After Forming Inverse Head & Shoulders Pattern https://t.co/m6FGKLtPOv March 14th 2019, 10:03am |
 |
@guru_wall $fprx great presentation from Five Prime today. Love what they are trying to achieve and looks like they are on track. March 14th 2019, 3:03am |
|
@guru_wall RT @SeekingAlpha: $FPRX - Five Prime Therapeutics (FPRX) Presents At Cowen and Company 39th Annual Health Care Conference - Slideshow https… March 14th 2019, 2:03am |
 |
@SeekingAlpha $FPRX - Five Prime Therapeutics (FPRX) Presents At Cowen and Company 39th Annual Health Care Conference - Slideshow https://t.co/bbqrp96RIa March 13th 2019, 4:03pm |
|
@mmahotstuff1 Institutional Investors Lead Shift in Five Prime Therapeutics Inc $FPRX Sentiment https://t.co/jVofQtlTWt March 13th 2019, 4:03pm |
|
@reurope_stock What Next for Five Prime Therapeutics, Inc. $FPRX Stock After Today's Big Increase? https://t.co/k9IwbU4hds March 13th 2019, 3:03pm |
|
@BlogYomi Comparing of Cellectar Biosciences Inc. $FPRX https://t.co/q1gUNFkTOh March 12th 2019, 9:03pm |
 |
@InnDeptInvestor With #ChinaDeal In-Play $FPRX is finally ripe for +30% BIG VOLUME DAY into new resistance $15-17 level. Has to be r… https://t.co/8Or6uMPijk March 12th 2019, 5:03pm |
 |
@macondailynews Analysts Set Five Prime Therapeutics Inc $FPRX Price Target at $24.29 https://t.co/zWMJayI0OA March 12th 2019, 9:03am |
 |
@budfoxhub On March 8, 2019, Progressive Care Inc. executed an agreement to purchase 100% of the stock in Family Phys $FPRX… https://t.co/N88b6RsDGW March 12th 2019, 8:03am |
|
@mmahotstuff1 Discussion stirs around Five Prime Therapeutics, Inc. $FPRX this week; here is what analysts are saying. https://t.co/dO0ir470gU March 10th 2019, 2:03pm |
|
@whatsonthorold2 How Many Five Prime Therapeutics, Inc. $FPRX's Analysts Are Bullish? https://t.co/2WqYdPD8km March 10th 2019, 2:03pm |
|
@bibeypost_stock Are Analysts Bullish about Five Prime Therapeutics, Inc. $FPRX after last week? https://t.co/fWbsbFcra0 March 10th 2019, 2:03pm |
 |
@bulletin_en Contrasting of ZIOPHARM Oncology Inc. $FPRX https://t.co/NmZT5VAPOT March 9th 2019, 8:03pm |
|
@BlogYomi Xeris Pharmaceuticals Inc. $FPRX Comparing side by side https://t.co/oam9X4qZqn March 9th 2019, 8:03pm |
 |
@AmericanBanking Five Prime Therapeutics Inc $FPRX Given Consensus Recommendation of “Buy” by Brokerages https://t.co/e88Q9zdnUN #stocks March 9th 2019, 4:03pm |
 |
@dispatchtribune Five Prime Therapeutics Inc $FPRX Given Consensus Recommendation of “Buy” by Analysts https://t.co/M6TWnmhiKk March 9th 2019, 4:03pm |
|
@whatsonthorold2 Five Prime Therapeutics Inc $FPRX Institutional Investors Sentiment Index Increased in Q4 2018 https://t.co/mIZ7WgMAOe March 9th 2019, 11:03am |
|
@bulletin_en Reviewing Strongbridge Biopharma plc $FPRX's results https://t.co/eiOeVE8A3O March 9th 2019, 7:03am |
|
@AmericanBanking Five Prime Therapeutics Inc $FPRX Expected to Announce Quarterly Sales of $8.20 Million https://t.co/aIhs1GZXnO #stocks March 9th 2019, 2:03am |
|
@thefinreviewer Comparison of Altimmune Inc. $FPRX https://t.co/iYdMp6y2Ib March 8th 2019, 8:03pm |
 |
@1stOncology #FivePrimeTherapeutics to Present at Cowen and Company 39th Annual #HealthCareConference $FPRX https://t.co/B65qiowYFC March 7th 2019, 8:03am |
|
@thefinreviewer ZIOPHARM Oncology Inc. $FPRX https://t.co/lnhF3xZ7cM March 7th 2019, 8:03am |
 |
@FinZTribune Summary of Five Prime Therapeutics, Inc. $FPRX Ratings on Mar 6, 2019 https://t.co/qXfpCc7H4Q March 6th 2019, 6:03am |
|
@bulletin_en Summary of Five Prime Therapeutics, Inc. $FPRX Ratings on Mar 6, 2019 https://t.co/6hejC7JxfH March 6th 2019, 6:03am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.